iShares Nasdaq US Biotechnology
(BTEK)
£5.40
Previous business day’s close price
+£0.41 (+8.3%)
max available period
£3.91
£5.65
04 Jan 21
24 Jul 24
Details
This ETF tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease, via the Nasdaq Biotechnology index. This ETF reinvests income.
Ticker: BTEK
ISIN: IE00BYXG2H39
Ticker: BTEK
ISIN: IE00BYXG2H39
Key information
ETF Breakdown
Gilead Sciences, Inc.
8.4%
Regeneron Pharmaceuticals, Inc.
8.0%
AMGEN Inc.
8.0%
Vertex Pharmaceuticals, Inc.
7.9%
Moderna Inc
4.5%
Astrazeneca plc
3.7%
Biogen Inc
3.2%
Alnylam Pharmaceuticals Inc
3.0%
Illumina Inc
1.8%
Biomarin Pharmaceutical Inc.
1.6%
argenx SE
1.5%
Incyte Corp.
1.5%
Neurocrine Biosciences, Inc.
1.4%
United Therapeutics Corp
1.4%
Sanofi
1.4%
Viatris Inc
1.4%
Sarepta Therapeutics Inc
1.4%
Medpace Holdings Inc
1.3%
Royalty Pharma plc
1.3%
Insmed Inc
1.2%
Vaxcyte Inc
0.9%
BioNTech SE
0.8%
Myovant Sciences Ltd
0.8%
Ascendis Pharma A/S
0.8%
Intra‑Cellular Therapies Inc
0.8%
Revolution Medicines Inc
0.8%
Blueprint Medicines Corp
0.7%
Halozyme Therapeutics Inc.
0.7%
Ionis Pharmaceuticals Inc
0.7%
Jazz Pharmaceuticals plc
0.7%
Summit Therapeutics Inc
0.7%
Exelixis Inc
0.7%
BeiGene Ltd
0.6%
Cytokinetics Inc
0.6%
Canticle Pharmaceuticals Inc
0.6%
Krystal Biotech Inc
0.6%
BridgeBio Pharma Inc
0.5%
CRISPR Therapeutics AG
0.5%
Legend Biotech Corp
0.5%
Nuvalent Inc
0.5%
Apellis Pharmaceuticals Inc
0.5%
Avidity Biosciences Inc
0.4%
Alkermes plc
0.4%
Crinetics Pharmaceuticals Inc
0.4%
ImmunityBio Inc
0.4%
Immunovant Inc
0.4%
Dyne Therapeutics Inc
0.4%
Axsome Therapeutics Inc
0.4%
Guardant Health Inc
0.4%
Merus N.V
0.4%
Ultragenyx Pharmaceutical Inc.
0.3%
Arrowhead Pharmaceuticals Inc.
0.3%
Arcellx Inc
0.3%
Amicus Therapeutics Inc
0.3%
Denali Therapeutics Inc
0.3%
Ideaya Biosciences Inc
0.3%
Morphic Holding Inc
0.3%
Twist Bioscience Corp
0.3%
Xenon Pharmaceuticals Inc
0.3%
Adma Biologics Inc
0.3%
Rhythm Pharmaceuticals Inc.
0.3%
Acadia Pharmaceuticals Inc
0.3%
Agios Pharmaceuticals Inc
0.3%
Geron Corp.
0.3%
Kymera Therapeutics Inc
0.3%
SpringWorks Therapeutics Inc
0.3%
Intellia Therapeutics Inc
0.3%
PTC Therapeutics Inc
0.3%
Vericel Corp
0.3%
Myriad Genetics, Inc.
0.2%
Lion Biotechnologies Inc
0.2%
Fortrea Holdings Inc
0.2%
Apogee Therapeutics Ord Shs
0.2%
Beam Therapeutics Inc
0.2%
Novavax, Inc.
0.2%
Protagonist Therapeutics Inc
0.2%
Rocket Pharmaceuticals Inc
0.2%
Arvinas Operations Inc
0.2%
NovoCure Ltd
0.2%
Syndax Pharmaceuticals Inc
0.2%
Akero Therapeutics Inc
0.2%
Amphastar Pharmaceuticals Inc
0.2%
Edgewise Therapeutics Inc
0.2%
Vera Therapeutics Inc
0.2%
Harmony Biosciences Holdings Inc
0.2%
Ligand Pharmaceuticals, Inc.
0.2%
Mirum Pharmaceuticals Inc
0.2%
Recursion Pharmaceuticals Inc
0.2%
Structure Therapeutics Adr Inc
0.2%
Veracyte Inc
0.2%
Keros Therapeutics Inc
0.2%
Kura Oncology Inc
0.2%
Supernus Pharmaceuticals Inc
0.2%
Avadel Pharmaceuticals Ord
0.1%
Mannkind Corp
0.1%
Verona Pharma Plc
0.1%
Biocryst Pharmaceuticals Inc.
0.1%
Dynavax Technologies Corp.
0.1%
Immunocore Holdings plc
0.1%
Vir Biotechnology Inc
0.1%
Ardelyx Inc
0.1%
Day One Biopharmaceuticals Inc
0.1%
Sana Biotechnology Inc
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Nurix Therapeutics Inc
0.1%
Ocular Therapeutix Inc
0.1%
Prothena Corporation plc
0.1%
Xencor Inc
0.1%
Arcutis Biotherapeutics Inc
0.1%
Cullinan Oncology Inc
0.1%
Disc Medicine Inc Ord
0.1%
Enliven Therapeutics Inc Ord
0.1%
Genmab
0.1%
Innoviva Inc
0.1%
Relay Therapeutics Inc
0.1%
Collegium Pharmaceutical Inc
0.1%
Grifols SA
0.1%
Ironwood Pharmaceuticals Inc
0.1%
Silverback Therapeutics Inc
0.1%
Tango Therapeutics Inc
0.1%
Tarsus Pharmaceuticals Inc
0.1%
Zai Lab Limited
0.1%
AbCellera Biologics Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Autolus Therapeutics Adr Plc
< 0.1%
Harrow Health Inc
< 0.1%
Humacyte Inc
< 0.1%
Pacira BioSciences Inc
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
89bio Inc
< 0.1%
ANI Pharmaceuticals Inc
< 0.1%
Bicycle Therapeutics Plc
< 0.1%
Cogent Biosciences Inc
< 0.1%
CureVac N.V.
< 0.1%
Erasca Inc
< 0.1%
Kiniksa Pharmaceuticals Internatio
< 0.1%
Olema Pharmaceuticals Inc
< 0.1%
Travere Therapeutics Inc
< 0.1%
Acelyrin Inc.
< 0.1%
Arbutus Biopharma Corp
< 0.1%
Evolus Inc
< 0.1%
Lexicon Pharmaceuticals Inc
< 0.1%
Mineralys Therapeutics Ord
< 0.1%
Pliant Therapeutics Inc
< 0.1%
Prime Medicine Ord Shs
< 0.1%
SIGA Technologies Inc
< 0.1%
Sage Therapeutics Inc
< 0.1%
Savara Inc
< 0.1%
Scholar Rock Holding Corp
< 0.1%
Wave Life Sciences Ltd.
< 0.1%
Zymeworks Inc
< 0.1%
Adaptive Biotechnologies Corp
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
HUTCHMED (China) Limited
< 0.1%
ITeos Therapeutics Inc
< 0.1%
KalVista Pharmaceuticals Inc
< 0.1%
ORIC Pharmaceuticals Inc
< 0.1%
PetIQ Inc
< 0.1%
Phathom Pharmaceuticals Inc
< 0.1%
Regenxbio Inc
< 0.1%
Replimune Group Inc
< 0.1%
Terns Pharmaceuticals Inc
< 0.1%
UroGen Pharma Ltd
< 0.1%
Alector Inc
< 0.1%
Castle Biosciences Inc
< 0.1%
Centessa Pharmaceuticals plc
< 0.1%
EyePoint Pharmaceuticals Inc
< 0.1%
Fulcrum Therapeutics Inc
< 0.1%
Galapagos NV
< 0.1%
MaxCyte Inc
< 0.1%
Omniab Inc
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
Theravance Biopharma Inc
< 0.1%
Third Harmonic Bio Ord Shs
< 0.1%
Verve Therapeutics Inc
< 0.1%
Voyager Therapeutics Inc
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Alx Oncology Holdings Inc
< 0.1%
Anavex Life Sciences Corporation
< 0.1%
Editas Medicine Inc
< 0.1%
Gralv
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Nautilus Biotechnology Inc
< 0.1%
Phibro Animal Health Corp.
< 0.1%
Precigen Inc
< 0.1%
Revance Therapeutics Inc
< 0.1%
Taysha Gene Therapies Inc
< 0.1%
Tourmaline Bio Inc
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Ac Immune Sa
< 0.1%
Amarin Corp
< 0.1%
Atea Pharmaceuticals Inc
< 0.1%
Cabaletta Bio Inc
< 0.1%
Exscientia Plc
< 0.1%
Macrogenics Inc
< 0.1%
MeiraGTx Holdings plc
< 0.1%
Xeris Biopharma Holdings Inc
< 0.1%
Zentalis Pharmaceuticals Inc
< 0.1%
uniQure N.V.
< 0.1%
Biomea Fusion Inc
< 0.1%
Bluebird bio Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Coherus Biosciences Inc
< 0.1%
Ventyx Biosciences Inc
< 0.1%
23Andme Holding Class A
< 0.1%
Aclaris Therapeutics Inc
< 0.1%
Amylyx Pharmaceuticals Inc
< 0.1%
Marinus Pharmaceuticals Inc
< 0.1%
Ovid Therapeutics Inc
< 0.1%
RAPT Therapeutics Inc
< 0.1%
Reneo Pharmaceuticals Inc
< 0.1%
Others
0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
82.2%
Europe ex‑UK
6.1%
UK
4.1%
Asia ex‑Japan
0.1%
Emerging Markets
0.1%
Rest of the World
6.9%
Healthcare
58.5%
Industrial
20.3%
Technology
7.8%
Consumer
< 0.1%
Sector ‐ Other
13.0%
Why InvestEngine
Unbeatable value
From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it
Here's how we're able to do it
Choice of 670+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
